VolitionRx Limited Cash
VolitionRx Limited (VNRX) had Cash of $22.90 million as of 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Balance Sheet › Assets › Cash and Cash Equivalent
us-gaap:Cash · last filed 2021-11-10
- 2021-09-30: Cash $22.90M.
- 2021-06-30: Cash $27.90M.
- 2021-03-31: Cash $33.10M.
- 2020-06-30: Cash $21.31M.
| Period end | Cash |
|---|---|
| 2021-09-30 | $22.90M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $27.90M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $33.10M 10-Q · filed 2021-05-11 |
| 2020-06-30 | $21.31M 10-Q · filed 2020-08-13 |
| 2019-12-31 | $16.97M 10-Q · filed 2020-08-13 |
| 2018-12-31 | $13.43M 10-K · filed 2020-02-20 |
| 2015-12-31 | $5.92M 10-K · filed 2016-03-11 |
| 2015-09-30 | $6.85M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $9.31M 10-Q · filed 2015-08-11 |
| 2015-03-31 | $11.03M 10-Q · filed 2015-05-12 |
| 2014-12-31 | $2.14M 10-K · filed 2016-03-11 |
| 2014-09-30 | $2.42M 10-Q · filed 2015-11-04 |
| 2014-06-30 | $1.81M 10-Q · filed 2015-08-11 |
| 2014-03-31 | $2.80M 10-Q · filed 2015-05-12 |
| 2013-12-31 | $888.70K 10-K · filed 2016-03-11 |
| 2013-09-30 | $473.48K 10-Q · filed 2014-11-06 |
| 2013-06-30 | $750.75K 10-Q · filed 2014-08-01 |
| 2013-03-31 | $410.87K 10-Q · filed 2014-05-15 |
| 2012-12-31 | $376.42K 10-K · filed 2015-03-18 |
| 2012-09-30 | $315.28K 10-Q · filed 2012-11-14 |
| 2012-03-31 | $217.81K 10-Q · filed 2012-05-15 |
| 2011-12-31 | $347.89K 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |